Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
The National Pharmaceutical Council’s Monday CER Daily Newsfeed included The American Journal of Managed Care® (AJMC®)’s article “Seema Verma Envisions a US Health System That Shares Data, Is Truly Value-Based,” in which CMS Administrator Seema Verma told AJMC® in written responses that our current healthcare system is complex, opaque, and difficult to navigate for patients. According to Verma, empowering patients starts with giving them access to their own personal health data.
OBR Oncology’s Tuesday newsfeed included AJMC®’s coverage of the American Society of Clinical Oncology (ASCO) Annual Meeting 2019. The article “How Real-World Data Can Impact NSCLC Treatment” covered several abstracts from the meeting that focused on using real-world data to advance research and cancer care in non—small cell lung cancer. The article “Oncology Reimbursement Reform Leaves Stakeholders With More Questions Than Answers” covered a session in which oncologists and representatives from UnitedHealthcare and the Center for Medicare and Medicaid Innovation (CMMI) took the stage to discuss oncology reimbursement reform and whether there are changes on the horizon for the promotion of higher value care.
Wednesday’s newsfeed included the AJMC® article “COA Urges Delay in Downside Risk Deadline for OCM,” which covered a letter from the Community Oncology Alliance to CMMI urging a delay in the October 2019 deadline for practices in the Oncology Care Model that have not yet achieved shared savings payments to make a decision on 2-sided risk.
Thursday's newsfeed included an article from AJMC®’s sister site The Center for Biosimilars®. The article, “Amgen’s Trastuzumab Biosimilar, Kanjiti, Clinically Similar to Herceptin in Cardiac Safety,” covered findings presented at ASCO that surrounded the cardiac safety of Amgen’s biosimilar trastuzumab, ABP 980, versus the reference trastuzumab, Herceptin.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Wearable Activity Tracker Data Enhance Patient Assessment in Lung Cancer
March 28th 2024This analysis included 119 patients with advanced lung cancer, who were evaluated on 3 facets of physical activity over 14 days of using the amuelink wearable device from Sony: metabolic equivalent tasks, distance walked, and steps taken.
Read More